Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 4
2011 3
2012 2
2013 4
2014 10
2015 12
2016 11
2017 8
2018 14
2019 10
2020 9
2021 25
2022 33
2023 25
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Results by year

Filters applied: . Clear all
Page 1
Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial.
Bartsch R, Berghoff AS, Furtner J, Marhold M, Bergen ES, Roider-Schur S, Starzer AM, Forstner H, Rottenmanner B, Dieckmann K, Bago-Horvath Z, Haslacher H, Widhalm G, Ilhan-Mutlu A, Minichsdorfer C, Fuereder T, Szekeres T, Oehler L, Gruenberger B, Singer CF, Weltermann A, Puhr R, Preusser M. Bartsch R, et al. Among authors: haslacher h. Nat Med. 2022 Sep;28(9):1840-1847. doi: 10.1038/s41591-022-01935-8. Epub 2022 Aug 8. Nat Med. 2022. PMID: 35941372 Free PMC article. Clinical Trial.
CD38 Antibody Daratumumab for the Treatment of Chronic Active Antibody-mediated Kidney Allograft Rejection.
Doberer K, Kläger J, Gualdoni GA, Mayer KA, Eskandary F, Farkash EA, Agis H, Reiter T, Reindl-Schwaighofer R, Wahrmann M, Cohen G, Haslacher H, Bond G, Simonitsch-Klupp I, Halloran PF, Böhmig GA. Doberer K, et al. Among authors: haslacher h. Transplantation. 2021 Feb 1;105(2):451-457. doi: 10.1097/TP.0000000000003247. Transplantation. 2021. PMID: 32235256
Preanalytical stability of SARS-CoV-2 anti-nucleocapsid antibodies.
Niedrist T, Kriegl L, Zurl CJ, Schmidt F, Perkmann-Nagele N, Mucher P, Repl M, Flieder I, Radakovics A, Sieghart D, Radner H, Aletaha D, Binder CJ, Gülly C, Krause R, Herrmann M, Wagner OF, Perkmann T, Haslacher H. Niedrist T, et al. Among authors: haslacher h. Clin Chem Lab Med. 2022 Nov 4;61(2):332-338. doi: 10.1515/cclm-2022-0875. Print 2023 Jan 27. Clin Chem Lab Med. 2022. PMID: 36323338 Free article.
Effect of monovalent COVID-19 vaccines on viral interference between SARS-CoV-2 and several DNA viruses in patients with long-COVID syndrome.
Gyöngyösi M, Lukovic D, Mester-Tonczar J, Zlabinger K, Einzinger P, Spannbauer A, Schweiger V, Schefberger K, Samaha E, Bergler-Klein J, Riesenhuber M, Nitsche C, Hengstenberg C, Mucher P, Haslacher H, Breuer M, Strassl R, Puchhammer-Stöckl E, Loewe C, Beitzke D, Hasimbegovic E, Zelniker TA. Gyöngyösi M, et al. Among authors: haslacher h. NPJ Vaccines. 2023 Sep 29;8(1):145. doi: 10.1038/s41541-023-00739-2. NPJ Vaccines. 2023. PMID: 37773184 Free PMC article.
Final outcome analysis from the phase II TUXEDO-1 trial of trastuzumab-deruxtecan in HER2-positive breast cancer patients with active brain metastases.
Bartsch R, Berghoff AS, Furtner J, Marhold M, Bergen ES, Roider-Schur S, Mair MJ, Starzer AM, Forstner H, Rottenmanner B, Aretin MB, Dieckmann K, Bago-Horvath Z, Haslacher H, Widhalm G, Ilhan-Mutlu A, Minichsdorfer C, Fuereder T, Szekeres T, Oehler L, Gruenberger B, Pfeiler G, Singer C, Weltermann A, Berchtold L, Preusser M. Bartsch R, et al. Among authors: haslacher h. Neuro Oncol. 2024 Jul 4:noae123. doi: 10.1093/neuonc/noae123. Online ahead of print. Neuro Oncol. 2024. PMID: 38963808
NT-proBNP in young healthy adults undergoing non-cardiac surgery.
Duma A, Maleczek M, Wagner C, Haslacher H, Szekeres T, Jaffe AS, Nagele P. Duma A, et al. Among authors: haslacher h. Clin Biochem. 2021 Oct;96:38-42. doi: 10.1016/j.clinbiochem.2021.07.009. Epub 2021 Jul 13. Clin Biochem. 2021. PMID: 34265286 Clinical Trial.
Humoral Immune Response in Hematooncological Patients and Health Care Workers Who Received SARS-CoV-2 Vaccinations.
Mair MJ, Berger JM, Berghoff AS, Starzer AM, Ortmayr G, Puhr HC, Steindl A, Perkmann T, Haslacher H, Strassl R, Tobudic S, Lamm WW, Raderer M, Mitterer M, Fuereder T, Fong D, Preusser M. Mair MJ, et al. Among authors: haslacher h. JAMA Oncol. 2022 Jan 1;8(1):106-113. doi: 10.1001/jamaoncol.2021.5437. JAMA Oncol. 2022. PMID: 34591965 Free PMC article.
Lupus-anticoagulant testing at NOAC trough levels.
Ratzinger F, Lang M, Belik S, Jilma-Stohlawetz P, Schmetterer KG, Haslacher H, Perkmann T, Quehenberger P. Ratzinger F, et al. Among authors: haslacher h. Thromb Haemost. 2016 Aug 1;116(2):235-40. doi: 10.1160/TH16-02-0081. Epub 2016 Apr 14. Thromb Haemost. 2016. PMID: 27075441
Moderate COVID-19 Disease Is Associated With Reduced Bone Turnover.
Kerschan-Schindl K, Dovjak P, Butylina M, Rainer A, Mayr B, Röggla V, Haslacher H, Weber M, Jordakieva G, Pietschmann P. Kerschan-Schindl K, et al. Among authors: haslacher h. J Bone Miner Res. 2023 Jul;38(7):943-950. doi: 10.1002/jbmr.4822. Epub 2023 May 18. J Bone Miner Res. 2023. PMID: 37126438 Free article.
155 results